Margaret Fang, MD

Professor in Residence

Hospital Medicine, Hospital Medicine UCSF Health

Margaret Fang is a clinician-investigator and the Research Director of the UCSF Division of Hospital Medicine. She also serves as the Medical Director of the UCSF Anticoagulation Clinic and the Director of the UCSF Academic Hospital Medicine Fellowship. After graduating from the Honors Program in Medical Education at Northwestern University Medical School, she completed her internal medicine residency training at the Beth Israel Deaconess Medical Center in Boston. She then obtained additional research training through a General Medicine Fellowship at the Massachusetts General Hospital and obtained a Masters of Public Health at the Harvard School of Public Health.
As a cardiovascular epidemiologist and clinical outcomes researcher, Margaret's research program focuses on how to optimize the use of anticoagulants to prevent stroke and treat venous thromboembolism. She is the Principal Investigator of the CVRN VTE and ALTERNATIVE Cohort Studies, cohorts of patients with venous thrombosis. She is also a core investigator in the ATRIA Study group, which investigates stroke and hemorrhage outcomes in patients with atrial fibrillation.

Education
2019 - Diversity, Equity, and Inclusion Champion Training, University of California
MPH, 2003 - , Harvard School of Public Health
General Medicine Fellowship, 2003 - , Massachusetts General Hospital
Internship/Residency, 2001 - Medicine, Beth Israel Deaconess Medical Center
MD, 1998 - , Northwestern University School of Medicine
BA, Molecular/Cell Biology, Honors Program in Medical Education, 1994 - , Northwestern University
Honors and Awards
  • Excellence in Research Award, Society of Hospital Medicine, 2010
  • Paul B. Beeson Career Development Award In Aging Research, NIH, AFAR, 2006
  • Hartford Geriatrics Health Outcomes Research Scholar, AGS Foundation for Health In Aging, 2005
  • Clinician Investigator of the Year, California Society of General Internal Medicine, 2005
  • Milton W. Hamolsky Award for best research abstract, Society of General Internal Medicine, 2005
  • Elizabeth Barrett-Connor Young Investigator Award, American Heart Association, 2004
  • Associate of the Year, Massachusetts American College of Physicians, 2002
  • Joseph E. Johnson National Leadership and Recognition Award, American College of Physicians, 2001
  • Lowell McGee Award for top resident teacher, Beth Israel Deaconess Medical Center, 2001
  • James Tullis Award for exceptional intellectual enthusiasm, Beth Israel Deaconess Medical Center, 2000
  • Jonathan Phillip Reder Award for excellence in academic and extracurricular activities, Northwestern University Medical School, 1997
  • A&O Award for Upcoming Student Leader, Northwestern University, 1994
Websites
Publications
  1. Parks AL, Auerbach AD, Schnipper JL, Anstey JE, Sterken DG, Hecht TEH, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic. 2020. PMID: 32977136


  2. Shah SJ, Barish PN, Prasad PA, Kistler A, Neff N, Kamm J, Li LM, Chiu CY, Babik JM, Fang MC, Kangelaris KN, Langelier C, Abe-Jones Y, Alipanah N, Alvarez FN, Botvinnik OB, Castaneda G. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19. 2020. PMID: 32864588


  3. Auerbach A, O'Leary KJ, Greysen SR, Harrison JD, Kripalani S, Ruhnke GW, Vasilevskis EE, Maselli J, Fang MC, Herzig SJ, Lee T. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers. 2020. PMID: 32804610


  4. Harrison JD, Archuleta M, Avitia E, Banta J, Benn J, Burden M, Chopra V, Coker R, Eid S, Fang MC, Fletcher K, Hagan J, Jaranilla J, Mullick M, Nyenpan C, Silva L, Wurst M, Ziegler G, Leykum L. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study. 2020. PMID: 32490806


  5. Sachin J Shah, Margaret Fang, Sun Y Jeon, Steven E Gregorich, Ken E Covinsky. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans. 2020. PMID:


  6. Shah SJ, Barish PN, Prasad PA, Kistler AL, Neff N, Kamm J, Li LM, Chiu CY, Babick JM, Fang MC, Abe-Jones Y, Alipanah N, Alvarez FN, Botvinnik OB, Davis JM, Castenada GD, Consortium C, Dadasovich RM, Deng X, DeRisi JL, Detweiler AM, Federman S, Haliburton JR, Hao SL, Kerkhoff AD, Kumar R, Malcolm K, Mann SA, Martinez SP, Marya R, Mick E, Mwakibete LL, Najafi N, Peluso MJ, Phelps MS, Pisco AO, Ratnasiri K, Rubio LA, Sellas AB, Sherwood KD, Sheu J, Spottiswoode N, Tan M, Yu G, Kangelaris KN, Langelier C. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19. 2020. PMID: 32511488


  7. Sachin J Shah, Margaret C Fang, Sun Jeon, Steven Gregorich, Kenneth Covinsky. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation. 2020. PMID:


  8. Barkoudah E, Piazza G, Hecht TEH, Grant P, Deitelzweig S, Fang MC, Fanikos J, Kao CK, Barnes GD, Chen T, Ramishvili T, Schnipper JL, Goldstein JN, Ruff CT, Kaatz S, Schwartz A, Connors JM, Goldhaber SZ. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative. 2020. PMID: 32362349


  9. Kulkarni SA, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply. 2020. PMID: 32310287


  10. Baumgartner C, Go AS, Fan D, Sung SH, Witt DM, Schmelzer JR, Williams MS, Yale SH, VanWormer JJ, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study. 2020. PMID: 32199174


  11. Prasad PA, Fang MC, Abe-Jones Y, Calfee CS, Matthay MA, Kangelaris KN. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment. 2020. PMID: 31939788


  12. Volgman AS, Bairey Merz CN, Benjamin EJ, Curtis AB, Fang MC, Lindley KJ, Pepine CJ, Vaseghi M, Waldo AL, Wenger NK, Russo AM. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Sex and Race/Ethnicity Differences in Atrial Fibrillation. 2019. PMID: 31779796


  13. Kulkarni SA, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Bridging Anticoagulation Therapy: A Teachable Moment. 2019. PMID: 31764945


  14. Jacobs ZG, Prasad PA, Fang MC, Abe-Jones Y, Kangelaris KN. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. The Association between Limited English Proficiency and Sepsis Mortality. 2019. PMID: 31891556


  15. Zachary G Jacobs, Priya A Prasad, Margaret C Fang, Yumiko Abe-Jones, Kirsten N Kangelaris. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. The Association between Limited English Proficiency and Sepsis Mortality. 2019. PMID:


  16. Shah SJ, Singer DE, Fang MC, Reynolds K, Go AS, Eckman MH. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation. 2019. PMID: 31707823


  17. Tarn DM, Barrientos M, Wang AY, Ramaprasad A, Fang MC, Schwartz JB. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban. 2019. PMID: 31658372


  18. Fang MC, Fan D, Sung SH, Witt DM, Schmelzer JR, Williams MS, Yale SH, Baumgartner C, Go AS. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study. 2019. PMID: 31247183


  19. Baumgartner C, Maselli J, Auerbach AD, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study. 2019. PMID: 31236894


  20. Ghazvinian R, White RH, Gage BF, Fang MC, Saeed R, Khanna RR. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Predictive value of the present-on-admission indicator for hospital-associated hemorrhage. 2019. PMID: 31163300


  21. Yao J, Ghosh K, Perraillon MC, Cutler DM, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013. 2019. PMID: 30870384


  22. Piccini JP, Xu H, Cox M, Matsouaka RA, Fonarow GC, Butler J, Curtis AB, Desai N, Fang M, McCabe PJ, Page RL, Turakhia M, Russo AM, Knight BP, Sidhu M, Hurwitz JL, Ellenbogen KA, Lewis WR. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB). 2019. PMID: 30700141


  23. Jacobs ZG, Najafi N, Fang MC, Prasad PA, Abe-Jones Y, Auerbach AD, Patel S. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative. 2019. PMID: 30811319


  24. Reading SR, Black MH, Singer DE, Go AS, Fang MC, Udaltsova N, Harrison TN, Wei RX, Liu IA, Reynolds K. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Risk factors for medication non-adherence among atrial fibrillation patients. 2019. PMID: 30744554


  25. Baumgartner C, de Kouchkovsky I, Whitaker E, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review. 2019. PMID: 30659809


  26. Groningen NV, Prasad PA, Najafi N, Rajkomar A, Khanna RR, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload. 2018. PMID: 30156577


  27. Baumgartner C, Fan D, Fang MC, Singer DE, Witt DM, Schmelzer JR, Williams MS, Gurwitz JH, Sung SH, Go AS. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study. 2018. PMID: 29656278


  28. Sankaran S, Ravi PS, Wu YE, Shanabogue S, Ashok S, Agnew K, Fang MC, Khanna RA, Dandu M, Harrison JD. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India. 2017. PMID: 29284700


  29. Patel H, Fang MC, Mourad M, Green A, Wachter RM, Murphy RD, Harrison JD. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers. 2017. PMID: 29240850


  30. . COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism. 2017. PMID:


  31. Fang MC, Fan D, Sung SH, Witt DM, Schmelzer JR, Steinhubl SR, Yale SH, Go AS. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study. 2017. PMID: 29135777


  32. Weiss R, Vittinghoff E, Fang MC, Cimino JEW, Chasteen KA, Arnold RM, Auerbach AD, Anderson WG. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters. 2017. PMID: 28991945


  33. Monash B, Fang MC, Harrison J. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial" 2017. PMID: 29190306


  34. Schwartz J, Merrill S, de Leon N, Thompson A, Fang M. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center. 2017. PMID: 28699943


  35. Chu JN, Maselli J, Auerbach AD, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty. 2017. PMID: 28501678


  36. Reading SR, Go AS, Fang MC, Singer DE, Liu IA, Black MH, Udaltsova N, Reynolds K. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Health Literacy and Awareness of Atrial Fibrillation. 2017. PMID: 28400367


  37. Parks AL, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding. 2017. PMID: 28359135


  38. Monash B, Najafi N, Mourad M, Rajkomar A, Ranji SR, Fang MC, Glass M, Milev D, Ding Y, Shen A, Sharpe BA, Harrison JD. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial. 2017. PMID: 28272589


  39. McGrath ER, Go AS, Chang Y, Borowsky LH, Fang MC, Reynolds K, Singer DE. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke. 2016. PMID: 28039855


  40. Ashburner JM, Go AS, Chang Y, Fang MC, Fredman L, Applebaum KM, Singer DE. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study. 2016. PMID: 27861698


  41. Rajkomar A, McCulloch CE, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients. 2016. PMID: 27452681


  42. Dallalzadeh LO, Go AS, Chang Y, Borowsky LH, Fang MC, Singer DE. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. 2016. PMID: 27451456


  43. Quinn GR, Singer DE, Chang Y, Go AS, Borowsky LH, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation? 2016. PMID: 27394408


  44. Patel H, Fang MC, Harrison JD, Auerbach A, Kangelaris KN. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group. 2016. PMID: 27294477


  45. Quinn GR, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. How can I predict bleeding in my elderly patient taking anticoagulants? 2016. PMID: 27168509


  46. Fang MC, Fan D, Sung SH, Witt DM, Schmelzer JR, Steinhubl SR, Yale SH, Go AS. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study. 2016. PMID: 26918401


  47. Parks AL, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Anticoagulation in Older Adults with Multimorbidity. 2016. PMID: 27113150


  48. Samuelson B, Go AS, Sung SH, Fan D, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study. 2016. PMID: 27253585


  49. Ashburner JM, Go AS, Chang Y, Fang MC, Fredman L, Applebaum KM, Singer DE. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study. 2016. PMID: 26796386


  50. Delate T, Hsiao W, Kim B, Witt DM, Meyer MR, Go AS, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism. 2015. PMID: 26585762


  51. Meyer MR, Witt DM, Delate T, Johnson SG, Fang M, Go A, Clark NP. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Thrombophilia testing patterns amongst patients with acute venous thromboembolism. 2015. PMID: 26477821


  52. Fang MC, Fan D, Sung SH, Witt DM, Yale SH, Steinhubl SR, Go AS. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study. 2015. PMID: 25894761


  53. Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Implications of the new atrial fibrillation guideline. 2015. PMID: 25730502


  54. Parekh AM, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Care as a continuum: will hospital outcomes be influenced by outpatient care? 2014. PMID: 25545772


  55. Wendy Hsiao, Thomas Delate, Daniel M Witt, Melissa R Meyer, Alan Go, Margaret Fang, Benjamin Kim. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism. 2014. PMID:


  56. Freeman JV, Reynolds K, Fang M, Udaltsova N, Steimle A, Pomernacki NK, Borowsky LH, Harrison TN, Singer DE, Go AS. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study. 2014. PMID: 25414270


  57. Ashburner JM, Go AS, Reynolds K, Chang Y, Fang MC, Fredman L, Applebaum KM, Singer DE. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts). 2014. PMID: 25456871


  58. Lewis WR, Piccini JP, Turakhia MP, Curtis AB, Fang M, Suter RE, Page RL, Fonarow GC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation. 2014. PMID: 25185244


  59. Goldsweig AM, Reid KJ, Gosch K, Tang F, Fang MC, Maddox TM, Chan PS, Cohen DJ, Chen J. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Contemporary use of dual antiplatelet therapy for preventing cardiovascular events. 2014. PMID: 25295680


  60. Quinn GR, Singer DE, Chang Y, Go AS, Borowsky LH, Udaltsova N, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin. 2014. PMID: 25001151


  61. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. 2014. PMID: 24788967


  62. Fang MC, Coca Perraillon M, Ghosh K, Cutler DM, Rosen AB. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008. 2014. PMID: 24680794


  63. Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Long-term survival after ischemic stroke in patients with atrial fibrillation. 2014. PMID: 24532273


  64. Shoeb M, Khanna R, Fang M, Sharpe B, Finn K, Ranji S, Monash B. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies. Volume 9 of Issue 4. 2014. PMID: 24493566


  65. Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Eby CS, Madigan RA, McBane RB, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER, Fang MC, Shah V, Horenstein RB, Limdi NA, Muldowney JA, Gujral J, Delafontaine P, Desnick RJ, Ortel TL, Billett HH, Pendleton RC, Geller NL, Halperin JL, Goldhaber SZ, Caldwell MD, Califf RM, Ellenberg JH. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. A pharmacogenetic versus a clinical algorithm for warfarin dosing. 2013. PMID: 24251361


  66. Auerbach A, Fang M, Glasheen J, Brotman D, O'Leary KJ, Horwitz LI. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. BOOST: evidence needing a lift. 2013. PMID: 23873749


  67. Singer DE, Chang Y, Borowsky LH, Fang MC, Pomernacki NK, Udaltsova N, Reynolds K, Go AS. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. 2013. PMID: 23782923


  68. Shoeb M, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Assessing bleeding risk in patients taking anticoagulants. 2013. PMID: 23479259


  69. . COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY. 2013. PMID:


  70. Quinn GR, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Atrial fibrillation: stroke prevention in older adults. 2012. PMID: 23101573


  71. Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants. 2012. PMID: 22539546


  72. You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, Hylek EM, Schulman S, Go AS, Hughes M, Spencer FA, Manning WJ, Halperin JL, Lip GYH. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 2012. PMID: 22315271


  73. Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Selecting the optimal stroke prevention therapy in atrial fibrillation. 2011. PMID: 22041953


  74. Khanna RR, Karliner LS, Eck M, Vittinghoff E, Koenig CJ, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Performance of an online translation tool when applied to patient educational material. Volume 6 of Issue 9. 2011. PMID: 22034196


  75. . COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Transitions in Care: Inpatient Anticoagulation. 2011. PMID:


  76. Rennke S, Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Hazards of hospitalization: more than just "never events". 2011. PMID: 21824939


  77. Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. 2011. PMID: 21757117


  78. Fang MC, Maselli J, Lurie JD, Lindenauer PK, Pekow PS, Auerbach AD. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery. 2011. PMID: 21535390


  79. Fang MC. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Anticoagulation in people with atrial fibrillation. 2011. PMID: 21282259


  80. Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes in adults with acute pulmonary embolism who are discharged from emergency departments: the Cardiovascular Research Network Venous Thromboembolism study.., Implications of the new atrial fibrillation guideline.., Care as a continuum: will hospital outcomes be influenced by outpatient care?., Assessment of Algorithms to Identify Patients with Thrombophilia Following Venous Thromboembolism.., Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.., Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).., Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation.., Contemporary use of dual antiplatelet therapy for preventing cardiovascular events.., Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.., Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.., Trends in stroke rates, risk, and outcomes in the United States, 1988 to 2008.., Long-term survival after ischemic stroke in patients with atrial fibrillation.., Internal medicine rounding practices and the Accreditation Council for Graduate Medical Education core competencies.., A pharmacogenetic versus a clinical algorithm for warfarin dosing.., BOOST: evidence needing a lift.., A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.., Assessing bleeding risk in patients taking anticoagulants.., DIGOXIN AND RISK OF DEATH IN ADULTS WITH ATRIAL FIBRILLATION: THE ATRIA-CVRN STUDY.., Atrial fibrillation: stroke prevention in older adults.., Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants.., Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.., Selecting the optimal stroke prevention therapy in atrial fibrillation.., Performance of an online translation tool when applied to patient educational material.., Transitions in Care: Inpatient Anticoagulation.., Hazards of hospitalization: more than just "never events".., A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.., Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.., Anticoagulation in people with atrial fibrillation.., Warfarin discontinuation after starting warfarin for atrial fibrillation.., CHA2DS2-VASc risk scheme: not ready for clinical use.., Trends in thrombolytic use for ischemic stroke in the United States.., Venous thromboembolism prophylaxis in the United States: still room for improvement.., Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.., Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.., The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.., The net clinical benefit of warfarin anticoagulation in atrial fibrillation.., Trends in catheter ablation for atrial fibrillation in the United States.., Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.., Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.., Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.., Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.., Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).., The Reply:.., Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.., Atrial fibrillation in the elderly.., Death and disability from warfarin-associated intracranial and extracranial hemorrhages.., Preparing for "diastole": advanced training opportunities for academic hospitalists.., Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.., Health literacy and anticoagulation-related outcomes among patients taking warfarin.., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study.., Antithrombotic therapy for stroke prevention in atrial fibrillation.., Cost considerations surrounding current and future anticoagulant therapies.., Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.., Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine.., Anticoagulation for atrial fibrillation.., National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.., Chapter 15 Anticoagulant and Antiplatelet Drug Therapy in Atrial Fibrillation.. Warfarin discontinuation after starting warfarin for atrial fibrillation. 2010. PMID: 20959565


  81. Singer DE, Fang MC, Go AS. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19.., Hospital Ward Adaptation During the COVID-19 Pandemic: A National Survey of Academic Medical Centers.., Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.., Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant use in a National Cohort of Older Americans.., Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19.., Abstract 251: Geriatric Syndromes Associated With Reduced Anticoagulant Use in Older Adults With Atrial Fibrillation.., Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.., Unexpected Heparin-Induced Thrombocytopenia While Bridging-Reply.., Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.., Time to Recognition of Sepsis in the Emergency Department Using Electronic Health Record Data: A Comparative Analysis of Systemic Inflammatory Response Syndrome, Sequential Organ Failure Assessment, and Quick Sequential Organ Failure Assessment.., Sex and Race/Ethnicity Differences in Atrial Fibrillation.., Bridging Anticoagulation Therapy: A Teachable Moment.., The Association between Limited English Proficiency and Sepsis Mortality.., The Association between Limited English Proficiency and Sepsis Mortality.., Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.., Prevalence and Knowledge of Potential Interactions Between Over-the-Counter Products and Apixaban.., Treatment and Outcomes of Acute Pulmonary Embolism and Deep Venous Thrombosis: The Cardiovascular Research Network Venous Thromboembolism (CVRN VTE) Study.., Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.., Predictive value of the present-on-admission indicator for hospital-associated hemorrhage.., Trends and Racial Differences in First Hospitalization for Stroke and 30-Day Mortality in the US Medicare Population From 1988 to 2013.., Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).., Reducing Unnecessary Treatment of Asymptomatic Elevated Blood Pressure with Intravenous Medications on the General Internal Medicine Wards: A Quality Improvement Initiative.., Risk factors for medication non-adherence among atrial fibrillation patients.., Periprocedural Bridging in Patients with Venous Thromboembolism: A Systematic Review.., Electronic Order Volume as a Meaningful Component in Estimating Patient Complexity and Resident Physician Workload.., Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.., An NGO-Implemented Community-Clinic Health Worker Approach to Providing Long-Term Care for Hypertension in a Remote Region of Southern India.., Hospitalist and Internal Medicine Leaders' Perspectives of Early Discharge Challenges at Academic Medical Centers.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism.., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Associations of Physician Empathy with Patient Anxiety and Ratings of Communication in Hospital Admission Encounters.., Letter to the Editor, The Authors Reply, "What Can Be Done to Maintain Positive Patient Experience and Improve Residents' Satisfaction?" and vStandardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial"., Dosing Accuracy of Direct Oral Anticoagulants in an Academic Medical Center.., The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.., Health Literacy and Awareness of Atrial Fibrillation.., Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.., Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.., Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.., Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.., Low Diagnostic Utility of Rechecking Hemoglobins Within 24 Hours in Hospitalized Patients.., Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.., How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?., Implementation and evaluation of a "works-in-progress" session to promote scholarship in an academic hospitalist group.., How can I predict bleeding in my elderly patient taking anticoagulants?., Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.., Anticoagulation in Older Adults with Multimorbidity.., Initial management and outcomes after superficial thrombophlebitis: The Cardiovascular Research Network Venous Thromboembolism study.., Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.., Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.., Thrombophilia testing patterns amongst patients with acute venous thromboembolism.., Outcomes i